Literature DB >> 25392588

Effects of Ciji Hua'ai Baosheng granule formula (CHBGF) on life time, pathology, peripheral blood cells of tumor chemotherapy model mouse with H22 hepatoma carcinoma cells.

Shengyan Xi1, Rongjian Hong2, Jingru Huang3, Dawei Lu1, Linchao Qian1, Pengcheng Li1, Lei Wen1, Yanhui Wang1.   

Abstract

BACKGROUND: Ciji Hua'ai Baosheng Granule Formula (CHBGF) is a traditional Chinese empirical formula that can help the tumor patients who have received chemotherapy antagonize the toxin and side-effects so as to improve and prolong the life. This study is to evaluate the effects of CHBGF on improving life quality in terms of survival time, pathology of tumor tissue and ameliorating peripheral blood cells in mouse chemotherapy model with subcutaneous transplanted tumor or ascitic tumor of H22 hepatoma carcinoma cells at an overall level.
MATERIALS AND METHODS: 71 mice among the 92 Kunming mice were injected subcutaneously into the right anterior armpit with H22 hepatoma carcinoma cells, after 7 days, which had formed tumors and were used peritoneal injection of Cytoxan (CTX) (200mg/kg) to establish the mouse chemotherapy model with transplanted tumor, and then which were commensurately divided into 8 groups by random digits table. 21 mice were injected into peritoneal cavity to use CTX and the same method to establish the model. The groups for evaluating the effects on the survival time were the model, CHBGF and positive control group respectively with 7 mice in each group. The groups for evaluating the effects on anti-cancer were the model group, three treatment groups and positive control group with 10 mice in each group. The survival-time-observing groups were given intragastric administration of normal saline, CHBGF (64g/kg) once a day, and peritoneal injection of 5-Fluorouracil (25mg/kg) once every other day respectively. The survival time of each group was observed. The five anti-cancer-observing groups were given intragastric administration of normal saline, CHBGF (64g/kg, 32g/kg and 16g/kg) once a day, and peritoneal injection of 5-Fluorouracil (25mg/kg) once every other day respectively. After treatment for 21 days, the transplanted tumors were peeled off. Blood was collected through pricking eyeball and analyzed by hematology analyzer. And postchemotherapy transplanted tumor inhibition ratios were calculated. Pathological changes of tumor tissues and blood smears were observed with light microscope.
RESULTS: The life prolonging rate of CHBGF (64g/kg) group with transplanted tumor is 20.14%, and their survival time was longer than that of the 5-Fluorouracil group (P<0.05). Life prolonging rate of CHBGF (64g/kg) group with ascitic tumor is 64.15%, the survival time was longer than that of the model group (P<0.01) and the 5-Fluorouracil group (P<0.05). The growth of the transplanted tumor in model group was faster than that in CHBGF (64g/kg) group and 5-Fluorouracil group (P<0.05). The tumor average weight of the positive drug and the CHBGF (64g/kg, 32g/kg) groups was lighter than that of the model group (P<0.05 or P<0.01). The inhibition ratios of CHBGF (64g/kg, 32g/kg and 16g/kg) groups are 31.15%, 21.31%, and 13.11% respectively. Under light microscope, in the positive drug and three CHBGF groups the pathological deteriorated severity of tumor tissue observed was milder than that in the model group, the distribution of WBC in CHBGF groups was more obvious than that of the model and 5-Fluorouracil groups. The WBC and PLT decrease in CHBGF (64g/kg, 32g/kg and 16g/kg) groups is less than the model and the 5-Fluorouracil group (P<0.05 or P<0.01), the number of RBC and HGB just in the CHBGF (64g/kg) group was more than that of the model group or the 5-Fluorouracil group (P<0.05).
CONCLUSION: Ciji Hua'ai Baosheng Granule Formula can prolong the survival time of the mice chemotherapy model of both subcutaneous transplanted tumor and ascitic tumor of H22 hepatoma carcinoma cells, has some determinate inhibitory effects on the growth of subcutaneous transplanted tumor chemo-treated, and has the therapeutic effect on antagonizing decrease of WBC and PLT caused by chemotherapy.

Entities:  

Keywords:  Ciji Hua'ai Baosheng Granule Formula (CHBGF); H22 hepatoma carcinoma cell; ascitic tumor; pathology; peripheral blood cell; survival time; transplanted tumor; tumor chemotherapy model

Mesh:

Substances:

Year:  2014        PMID: 25392588      PMCID: PMC4202404          DOI: 10.4314/ajtcam.v11i4.16

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  6 in total

1.  Effects of hydroxy safflower yellow-A on tumor capillary angiogenesis in transplanted human gastric adenocarcinoma BGC-823 tumors in nude mice.

Authors:  Sheng-yan Xi; Qian Zhang; Chao-yang Liu; Hua Xie; Li-feng Yue; Xue-min Gao
Journal:  J Tradit Chin Med       Date:  2012-06       Impact factor: 0.848

2.  Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model.

Authors:  Qunchuan Zhuang; Fei Hong; Aling Shen; Liangpu Zheng; Jianwei Zeng; Wei Lin; Youqin Chen; Thomas J Sferra; Zhenfeng Hong; Jun Peng
Journal:  Int J Oncol       Date:  2012-01-03       Impact factor: 5.650

3.  Effects of Pien Tze Huang on angiogenesis in vivo and in vitro.

Authors:  A-ling Shen; Fei Hong; Li-ya Liu; Jiu-mao Lin; Qun-chuan Zhuang; Zhen-feng Hong; Jun Peng
Journal:  Chin J Integr Med       Date:  2012-07-22       Impact factor: 1.978

4.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

5.  [An experimental study on antitumor activity of psoralen on mammary cancer cell line EMT6 in vitro and in vivo].

Authors:  S Wu; Z Zhang; J Zhao
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  1998-05

6.  Hedyotis diffusa Willd extract inhibits HT-29 cell proliferation via cell cycle arrest.

Authors:  Minghe Lin; Jiumao Lin; Lihui Wei; Wei Xu; Zhenfeng Hong; Qiaoyan Cai; Jun Peng; Dezeng Zhu
Journal:  Exp Ther Med       Date:  2012-06-06       Impact factor: 2.447

  6 in total
  4 in total

Review 1.  Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma.

Authors:  Sheng-Yan Xi; Gerald Yosel Minuk
Journal:  World J Hepatol       Date:  2018-11-27

2.  Safety Evaluation of a New Traditional Chinese Medical Formula, Ciji-Hua'ai-Baosheng II Formula, in Adult Rodent Models.

Authors:  Biqian Fu; Xiangyang Zhai; Shengyan Xi; Lifeng Yue; Yanan Wang; Yingkun Qiu; Yuewen Gong; Yangxinzi Xu; Linchao Qian; Jingru Huang; Dawei Lu; Shuqiong Huang; Jing Wang; Jing Zhou; Di Wu; Yanhui Wang
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-14       Impact factor: 2.629

Review 3.  Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity.

Authors:  Wentao Jia; Lina Wang
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-11       Impact factor: 2.629

Review 4.  Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Authors:  Hor-Yue Tan; Serban San-Marina; Ning Wang; Ming Hong; Sha Li; Lei Li; Fan Cheung; Xiao-Yan Wen; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.